Tapewire

NYSE · USD

MET

METLIFE INC

Export transactions ↓
Tapewire entity
488
SEC CIK
0001099219
Parsed reports
1,091

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 13, 2019 Filed Dec 17, 2019 21:53 UTC GrantDeferred Share Equivalents · Derivative 212 $50.38 $10,680.56
Disclosure

SEC source: 0001099219-19-000255 · wf-form4_157661956722583.xml · derivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,485

Underlying: Common Stock · 212 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents.

F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 21:53 UTC GrantCommon Stock 442 $50.38 $22,267.96
Disclosure

SEC source: 0001099219-19-000255 · wf-form4_157661956722583.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,850

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 21:55 UTC GrantCommon Stock 146 $50.38 $7,355.48
Disclosure

SEC source: 0001099219-19-000257 · wf-form4_157661969659415.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,827

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 21:49 UTC GrantCommon Stock 44 $50.38 $2,216.72
Disclosure

SEC source: 0001099219-19-000253 · wf-form4_157661935347865.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,181

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 21:47 UTC GrantDeferred Share Equivalents · Derivative 21 $50.38 $1,057.98
Disclosure

SEC source: 0001099219-19-000251 · wf-form4_157661921710346.xml · derivative · entry 2

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,469

Underlying: Common Stock · 21 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents.

F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 21:47 UTC GrantCommon Stock 53 $50.38 $2,670.14
Disclosure

SEC source: 0001099219-19-000251 · wf-form4_157661921710346.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,203

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 21:44 UTC GrantCommon Stock 484 $50.38 $24,383.92
Disclosure

SEC source: 0001099219-19-000249 · wf-form4_157661906920059.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,573

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
November 19, 2019 Filed Nov 22, 2019 00:01 UTC
PAPPAS BILLEVP, Global Tech. & Ops.
GrantRestricted Stock Units · Derivative 54,934 $0.00 $0.00
Disclosure

SEC source: 0001099219-19-000233 · wf-form4_157438085422310.xml · derivative · entry 1

PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,934

Underlying: Common Stock · 54,934 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.

F2 · derivative.exercise_date: The Restricted Stock Units vest in substantially equal installments on each of the first three anniversaries of the grant date.

F2 · derivative.expiration_date: The Restricted Stock Units vest in substantially equal installments on each of the first three anniversaries of the grant date.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:51 UTC GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000217 · wf-form4_157013588868476.xml · nonDerivative · entry 1

MORRISON DENISE M · CIK 0001230166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,969

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:50 UTC GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000216 · wf-form4_157013581084373.xml · nonDerivative · entry 1

GUTIERREZ CARLOS M · CIK 0001185943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,003

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:49 UTC GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000214 · wf-form4_157013572245101.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,819

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:49 UTC GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000215 · wf-form4_157013574666892.xml · nonDerivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,059

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:48 UTC GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000213 · wf-form4_157013569443393.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,776

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:48 UTC GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000212 · wf-form4_157013567086554.xml · nonDerivative · entry 1

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,457

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:47 UTC GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000211 · wf-form4_157013564533107.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,569

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:47 UTC GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000210 · wf-form4_157013562017720.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,681

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:46 UTC GrantDeferred Share Equivalents · Derivative 267 $46.03 $12,290.01
Disclosure

SEC source: 0001099219-19-000209 · wf-form4_157013559453876.xml · derivative · entry 4

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,273

Underlying: Common Stock · 267 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · kind: The Reporting Person acquired these Deferred Share Equivalents pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock.

F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:46 UTC GrantCommon Stock 642 $48.71 $31,271.82
Disclosure

SEC source: 0001099219-19-000209 · wf-form4_157013559453876.xml · nonDerivative · entry 3

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,408

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

F2 · price: The Reporting Person acquired these Deferred Shares as of October 1, 2019. MetLife, Inc. calculated the number of Deferred Shares based on the closing price of its common stock on May 1, 2019 and June 18, 2019, respectively, consistent with its Board Chair fee arrangements calling for 50% of such fees to be paid in common stock.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:46 UTC GrantCommon Stock 284 $45.71 $12,981.64
Disclosure

SEC source: 0001099219-19-000209 · wf-form4_157013559453876.xml · nonDerivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,766

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

F2 · price: The Reporting Person acquired these Deferred Shares as of October 1, 2019. MetLife, Inc. calculated the number of Deferred Shares based on the closing price of its common stock on May 1, 2019 and June 18, 2019, respectively, consistent with its Board Chair fee arrangements calling for 50% of such fees to be paid in common stock.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:46 UTC GrantCommon Stock 1,494 $46.03 $68,768.82
Disclosure

SEC source: 0001099219-19-000209 · wf-form4_157013559453876.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,482

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:46 UTC GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000208 · wf-form4_157013556720627.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,137

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:46 UTC GrantDeferred Share Equivalents · Derivative 326 $46.03 $15,005.78
Disclosure

SEC source: 0001099219-19-000207 · wf-form4_157013554100735.xml · derivative · entry 2

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,447

Underlying: Common Stock · 326 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: The Reporting Person acquired these Deferred Share Equivalents pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock.

F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:46 UTC GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000207 · wf-form4_157013554100735.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,150

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
October 01, 2019 Filed Oct 3, 2019 20:45 UTC GrantCommon Stock 815 $46.03 $37,514.45
Disclosure

SEC source: 0001099219-19-000206 · wf-form4_157013551459846.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,089

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:54 UTC GrantCommon Stock 187 $48.37 $9,045.19
Disclosure

SEC source: 0001099219-19-000173 · wf-form4_156875365235769.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,754

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:59 UTC GrantCommon Stock 283 $48.37 $13,688.71
Disclosure

SEC source: 0001099219-19-000177 · wf-form4_156875396423898.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,961

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:44 UTC GrantDeferred Share Equivalents · Derivative 19 $48.37 $919.03
Disclosure

SEC source: 0001099219-19-000165 · wf-form4_156875304812283.xml · derivative · entry 2

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,122

Underlying: Common Stock · 19 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents.

F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:44 UTC GrantCommon Stock 48 $48.37 $2,321.76
Disclosure

SEC source: 0001099219-19-000165 · wf-form4_156875304812283.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,335

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:46 UTC GrantCommon Stock 38 $48.37 $1,838.06
Disclosure

SEC source: 0001099219-19-000167 · wf-form4_156875319746296.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,322

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 21:04 UTC GrantCommon Stock 27 $48.37 $1,305.99
Disclosure

SEC source: 0001099219-19-000181 · wf-form4_156875425242360.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,004

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 21:02 UTC
Lee EstherEVP & Chief Marketing Officer
GrantCommon Stock 114 $48.37 $5,514.18
Disclosure

SEC source: 0001099219-19-000179 · wf-form4_156875412237325.xml · nonDerivative · entry 1

Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,830

F1 · kind: Represents imputed reinvested dividends in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:56 UTC GrantDeferred Share Equivalents · Derivative 106 $48.37 $5,127.22
Disclosure

SEC source: 0001099219-19-000175 · wf-form4_156875379587820.xml · derivative · entry 3

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,814

Underlying: Common Stock · 106 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents.

F4 · timeliness: Represents imputed reinvestment of dividends on Deferred Share Equivalents.

F3 · price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:56 UTC GrantCommon Stock 493 $48.37 $23,846.41
Disclosure

SEC source: 0001099219-19-000175 · wf-form4_156875379587820.xml · nonDerivative · entry 1

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,642

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:51 UTC GrantCommon Stock 143 $48.37 $6,916.91
Disclosure

SEC source: 0001099219-19-000171 · wf-form4_156875349115847.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,866

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:49 UTC GrantDeferred Share Equivalents · Derivative 216 $48.37 $10,447.92
Disclosure

SEC source: 0001099219-19-000169 · wf-form4_156875335986291.xml · derivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,006

Underlying: Common Stock · 216 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents.

F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:49 UTC GrantCommon Stock 435 $48.37 $21,040.95
Disclosure

SEC source: 0001099219-19-000169 · wf-form4_156875335986291.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,988

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
September 13, 2019 Filed Sep 17, 2019 20:40 UTC GrantCommon Stock 492 $48.37 $23,798.04
Disclosure

SEC source: 0001099219-19-000163 · wf-form4_156875278368229.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,274

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
August 21, 2019 Filed Aug 23, 2019 20:28 UTC GrantCommon Stock 244 $45.76 $11,165.44
Disclosure

SEC source: 0001099219-19-000147 · wf-form4_156659209414606.xml · nonDerivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 244

F1 · kind: MetLife, Inc.'s non-management Director compensation arrangements provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:54 UTC GrantCommon Stock 770 $48.71 $37,506.70
Disclosure

SEC source: 0001099219-19-000126 · wf-form4_156106407052496.xml · nonDerivative · entry 1

MORRISON DENISE M · CIK 0001230166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,154

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:54 UTC GrantCommon Stock 770 $48.71 $37,506.70
Disclosure

SEC source: 0001099219-19-000125 · wf-form4_156106404796349.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,977

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:54 UTC GrantCommon Stock 770 $48.71 $37,506.70
Disclosure

SEC source: 0001099219-19-000124 · wf-form4_156106402566967.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,679

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:53 UTC GrantCommon Stock 770 $48.71 $37,506.70
Disclosure

SEC source: 0001099219-19-000123 · wf-form4_156106400563592.xml · nonDerivative · entry 1

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,149

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:53 UTC GrantCommon Stock 770 $48.71 $37,506.70
Disclosure

SEC source: 0001099219-19-000121 · wf-form4_156106396544598.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,723

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:53 UTC GrantCommon Stock 770 $48.71 $37,506.70
Disclosure

SEC source: 0001099219-19-000122 · wf-form4_156106398537864.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,567

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:52 UTC GrantDeferred Share Equivalents · Derivative 1,026 $48.71 $49,976.46
Disclosure

SEC source: 0001099219-19-000120 · wf-form4_156106394543277.xml · derivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,790

Underlying: Common Stock · 1,026 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: The Reporting Person acquired these Deferred Share Equivalents pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock.

F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:52 UTC GrantCommon Stock 770 $48.71 $37,506.70
Disclosure

SEC source: 0001099219-19-000120 · wf-form4_156106394543277.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,553

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:52 UTC GrantCommon Stock 770 $48.71 $37,506.70
Disclosure

SEC source: 0001099219-19-000119 · wf-form4_156106392570998.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,284

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:51 UTC GrantCommon Stock 770 $48.71 $37,506.70
Disclosure

SEC source: 0001099219-19-000117 · wf-form4_156106388171410.xml · nonDerivative · entry 1

GUTIERREZ CARLOS M · CIK 0001185943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,188

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:51 UTC GrantDeferred Share Equivalents · Derivative 308 $48.71 $15,002.68
Disclosure

SEC source: 0001099219-19-000118 · wf-form4_156106390465228.xml · derivative · entry 2

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,102

Underlying: Common Stock · 308 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: The Reporting Person acquired these Deferred Share Equivalents pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock.

F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:51 UTC GrantCommon Stock 770 $48.71 $37,506.70
Disclosure

SEC source: 0001099219-19-000118 · wf-form4_156106390465228.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,287

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.